APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platelet Antibody Screening for Transfusion

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Platelet Antibody Screening for Transfusion Industry Growth and Trends Forecast to 2032

24 December 202591 pages

Choose your research edition.

Industry ResearchPlatelet Antibody Screening for Transfusion Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Platelet Antibody Screening for Transfusion Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Platelet Antibody Screening for Transfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platelet Antibody Screening for Transfusion Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Platelet Antibody Screening for Transfusion Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Platelet Antibody Screening for Transfusion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Platelet Antibody Screening for Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Platelet Antibody Screening for Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Platelet Antibody Screening for Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Platelet Antibody Screening for Transfusion include apDia, Werfen, Aikang MedTech, Tianjin Dexiang Biotech and Shanghai Jianglai, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Platelet Antibody Screening for Transfusion market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Platelet Antibody Screening for Transfusion market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Platelet Antibody Screening for Transfusion market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Platelet Antibody Screening for Transfusion.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Platelet Antibody Screening for Transfusion market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Platelet Antibody Screening for Transfusion Market by Company

apDia

Werfen

Aikang MedTech

Tianjin Dexiang Biotech

Shanghai Jianglai

Platelet Antibody Screening for Transfusion Segment by Type

Antibody Screening

Crossmatching

Platelet Antibody Screening for Transfusion Segment by Application

HLA Antibodies

HPA Antibodies

Platelet Antibody Screening for Transfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platelet Antibody Screening for Transfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platelet Antibody Screening for Transfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platelet Antibody Screening for Transfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Platelet Antibody Screening for Transfusion manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Platelet Antibody Screening for Transfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Antibody Screening Table 2. Major Company of Crossmatching Table 3. Global Platelet Antibody Screening for Transfusion Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 5. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type (2021-2026) Table 6. Global Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 7. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type (2021-2026) Table 8. Global Platelet Antibody Screening for Transfusion Price by Type (2021-2026) & (US$/Unit) Table 9. Global Platelet Antibody Screening for Transfusion Sales by Type (2027-2032) & (Units) Table 10. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type (2027-2032) Table 11. Global Platelet Antibody Screening for Transfusion Sales by Type (2027-2032) & (US$ Million) Table 12. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type (2027-2032) Table 13. Global Platelet Antibody Screening for Transfusion Price by Type (2027-2032) & (US$/Unit) Table 14. North America Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 15. North America Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 17. Europe Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 21. Latin America Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Type (2021-2026) & (US$ Million) Table 24. Platelet Antibody Screening for Transfusion Industry Trends Table 25. Platelet Antibody Screening for Transfusion Industry Drivers Table 26. Platelet Antibody Screening for Transfusion Industry Opportunities and Challenges Table 27. Platelet Antibody Screening for Transfusion Industry Restraints Table 28. Global Platelet Antibody Screening for Transfusion Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Platelet Antibody Screening for Transfusion Revenue Market Share by Company (2021-2026) Table 30. Global Platelet Antibody Screening for Transfusion Sales by Company (2021-2026) & (Units) Table 31. Global Platelet Antibody Screening for Transfusion Sales Share by Company (2021-2026) Table 32. Global Platelet Antibody Screening for Transfusion Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Platelet Antibody Screening for Transfusion Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Platelet Antibody Screening for Transfusion Major Company Production Sites and Headquarters Table 35. Global Platelet Antibody Screening for Transfusion Company, Product Type & Application Table 36. Global Platelet Antibody Screening for Transfusion Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Platelet Antibody Screening for Transfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Platelet Antibody Screening for Transfusion Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Platelet Antibody Screening for Transfusion Sales by Region (2021-2026) & (Units) Table 41. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Region (2021-2026) Table 42. Global Platelet Antibody Screening for Transfusion Sales by Region (2021-2026) & (US$ Million) Table 43. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Region (2021-2026) Table 44. Global Platelet Antibody Screening for Transfusion Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Platelet Antibody Screening for Transfusion Sales by Region (2027-2032) & (Units) Table 46. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Region (2027-2032) Table 47. Global Platelet Antibody Screening for Transfusion Sales by Region (2027-2032) & (US$ Million) Table 48. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Region (2027-2032) Table 49. Global Platelet Antibody Screening for Transfusion Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Platelet Antibody Screening for Transfusion Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 52. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application (2021-2026) Table 53. Global Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 54. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application (2021-2026) Table 55. Global Platelet Antibody Screening for Transfusion Price by Application (2021-2026) & (US$/Unit) Table 56. Global Platelet Antibody Screening for Transfusion Sales by Application (2027-2032) & (Units) Table 57. Global Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application (2027-2032) Table 58. Global Platelet Antibody Screening for Transfusion Sales by Application (2027-2032) & (US$ Million) Table 59. Global Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application (2027-2032) Table 60. Global Platelet Antibody Screening for Transfusion Price by Application (2027-2032) & (US$/Unit) Table 61. North America Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 62. North America Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 64. Europe Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 68. Latin America Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Application (2021-2026) & (US$ Million) Table 71. apDia Company Information Table 72. apDia Business Overview Table 73. apDia Platelet Antibody Screening for Transfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. apDia Platelet Antibody Screening for Transfusion Product Portfolio Table 75. apDia Recent Development Table 76. Werfen Company Information Table 77. Werfen Business Overview Table 78. Werfen Platelet Antibody Screening for Transfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Werfen Platelet Antibody Screening for Transfusion Product Portfolio Table 80. Werfen Recent Development Table 81. Aikang MedTech Company Information Table 82. Aikang MedTech Business Overview Table 83. Aikang MedTech Platelet Antibody Screening for Transfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Aikang MedTech Platelet Antibody Screening for Transfusion Product Portfolio Table 85. Aikang MedTech Recent Development Table 86. Tianjin Dexiang Biotech Company Information Table 87. Tianjin Dexiang Biotech Business Overview Table 88. Tianjin Dexiang Biotech Platelet Antibody Screening for Transfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Tianjin Dexiang Biotech Platelet Antibody Screening for Transfusion Product Portfolio Table 90. Tianjin Dexiang Biotech Recent Development Table 91. Shanghai Jianglai Company Information Table 92. Shanghai Jianglai Business Overview Table 93. Shanghai Jianglai Platelet Antibody Screening for Transfusion Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Shanghai Jianglai Platelet Antibody Screening for Transfusion Product Portfolio Table 95. Shanghai Jianglai Recent Development Table 96. North America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 97. North America Platelet Antibody Screening for Transfusion Sales by Country (2021-2026) & (Units) Table 98. North America Platelet Antibody Screening for Transfusion Sales Market Share by Country (2021-2026) Table 99. North America Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032) & (Units) Table 100. North America Platelet Antibody Screening for Transfusion Sales Market Share Forecast by Country (2027-2032) Table 101. North America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Platelet Antibody Screening for Transfusion Market Share by Country (2021-2026) Table 104. North America Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Platelet Antibody Screening for Transfusion Market Share Forecast by Country (2027-2032) Table 106. Europe Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 107. Europe Platelet Antibody Screening for Transfusion Sales by Country (2021-2026) & (Units) Table 108. Europe Platelet Antibody Screening for Transfusion Sales Market Share by Country (2021-2026) Table 109. Europe Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032) & (Units) Table 110. Europe Platelet Antibody Screening for Transfusion Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Platelet Antibody Screening for Transfusion Market Share by Country (2021-2026) Table 114. Europe Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Platelet Antibody Screening for Transfusion Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Country (2021-2026) & (Units) Table 118. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032) & (Units) Table 120. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Platelet Antibody Screening for Transfusion Market Share by Country (2021-2026) Table 124. Asia-Pacific Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Platelet Antibody Screening for Transfusion Market Share Forecast by Country (2027-2032) Table 126. Latin America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 127. Latin America Platelet Antibody Screening for Transfusion Sales by Country (2021-2026) & (Units) Table 128. Latin America Platelet Antibody Screening for Transfusion Sales Market Share by Country (2021-2026) Table 129. Latin America Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032) & (Units) Table 130. Latin America Platelet Antibody Screening for Transfusion Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Platelet Antibody Screening for Transfusion Market Share by Country (2021-2026) Table 134. Latin America Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Platelet Antibody Screening for Transfusion Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Country (2021-2026) & (Units) Table 138. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032) & (Units) Table 140. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Platelet Antibody Screening for Transfusion Market Share by Country (2021-2026) Table 144. Middle East and Africa Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Platelet Antibody Screening for Transfusion Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Platelet Antibody Screening for Transfusion Distributors List Table 149. Platelet Antibody Screening for Transfusion Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Platelet Antibody Screening for Transfusion Image Figure 2. Global Platelet Antibody Screening for Transfusion Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Platelet Antibody Screening for Transfusion Market Size (2021-2032) & (US$ Million) Figure 4. Global Platelet Antibody Screening for Transfusion Sales (2021-2032) & (Units) Figure 5. Antibody Screening Image Figure 6. Global Antibody Screening Sales YoY Growth (2021-2032) & (Units) Figure 7. Crossmatching Image Figure 8. Global Crossmatching Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Platelet Antibody Screening for Transfusion Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Platelet Antibody Screening for Transfusion Market Share by Type 2025 VS 2032 Figure 11. North America Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type in 2025 Figure 12. North America Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type in 2025 Figure 13. Europe Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type in 2025 Figure 14. Europe Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type in 2025 Figure 17. Latin America Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Platelet Antibody Screening for Transfusion Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. HLA Antibodies Image Figure 24. Global HLA Antibodies Sales YoY Growth (2021-2032) & (Units) Figure 25. HPA Antibodies Image Figure 26. Global HPA Antibodies Sales YoY Growth (2021-2032) & (Units) Figure 27. Global Platelet Antibody Screening for Transfusion Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Platelet Antibody Screening for Transfusion Market Share by Application 2025 VS 2032 Figure 29. North America Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application in 2025 Figure 30. North America Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application in 2025 Figure 31. Europe Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application in 2025 Figure 32. Europe Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application in 2025 Figure 35. Latin America Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Market Share in Value by Application in 2025 Figure 39. North America Platelet Antibody Screening for Transfusion Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 40. North America Platelet Antibody Screening for Transfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Platelet Antibody Screening for Transfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Platelet Antibody Screening for Transfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Platelet Antibody Screening for Transfusion Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 44. Europe Platelet Antibody Screening for Transfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Platelet Antibody Screening for Transfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Platelet Antibody Screening for Transfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 48. Asia-Pacific Platelet Antibody Screening for Transfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Platelet Antibody Screening for Transfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Platelet Antibody Screening for Transfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Platelet Antibody Screening for Transfusion Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 52. Latin America Platelet Antibody Screening for Transfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Platelet Antibody Screening for Transfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Platelet Antibody Screening for Transfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 56. Middle East and Africa Platelet Antibody Screening for Transfusion Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Platelet Antibody Screening for Transfusion Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Platelet Antibody Screening for Transfusion Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Platelet Antibody Screening for Transfusion Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Platelet Antibody Screening for Transfusion Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Antibody Screening
  • Crossmatching
Applications
  • HLA Antibodies
  • HPA Antibodies
Companies covered
  • apDia
  • Werfen
  • Aikang MedTech
  • Tianjin Dexiang Biotech
  • Shanghai Jianglai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Platelet Antibody Screening for Transfusion Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Platelet Antibody Screening for Transfusion Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Platelet Antibody Screening for Transfusion Market by Type
  6. 1.3.1 Antibody Screening
  7. 1.3.2 Crossmatching
  8. 1.4 Global Platelet Antibody Screening for Transfusion Market Size by Type
  9. 1.4.1 Global Platelet Antibody Screening for Transfusion Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Platelet Antibody Screening for Transfusion Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Platelet Antibody Screening for Transfusion Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Platelet Antibody Screening for Transfusion Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Platelet Antibody Screening for Transfusion Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Platelet Antibody Screening for Transfusion Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Platelet Antibody Screening for Transfusion Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Platelet Antibody Screening for Transfusion Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Platelet Antibody Screening for Transfusion Industry Trends
  2. 2.2 Platelet Antibody Screening for Transfusion Industry Drivers
  3. 2.3 Platelet Antibody Screening for Transfusion Industry Opportunities and Challenges
  4. 2.4 Platelet Antibody Screening for Transfusion Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Platelet Antibody Screening for Transfusion Revenue (2021-2026)
  2. 3.2 Global Top Players by Platelet Antibody Screening for Transfusion Sales (2021-2026)
  3. 3.3 Global Top Players by Platelet Antibody Screening for Transfusion Price (2021-2026)
  4. 3.4 Global Platelet Antibody Screening for Transfusion Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Platelet Antibody Screening for Transfusion Major Company Production Sites & Headquarters
  6. 3.6 Global Platelet Antibody Screening for Transfusion Company, Product Type & Application
  7. 3.7 Global Platelet Antibody Screening for Transfusion Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Platelet Antibody Screening for Transfusion Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Platelet Antibody Screening for Transfusion Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Platelet Antibody Screening for Transfusion Tier 1, Tier 2, and Tier 3
4 Platelet Antibody Screening for Transfusion Regional Status and Outlook
  1. 4.1 Global Platelet Antibody Screening for Transfusion Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Platelet Antibody Screening for Transfusion Historic Market Size by Region
  3. 4.2.1 Global Platelet Antibody Screening for Transfusion Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Platelet Antibody Screening for Transfusion Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Platelet Antibody Screening for Transfusion Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Platelet Antibody Screening for Transfusion Forecasted Market Size by Region
  7. 4.3.1 Global Platelet Antibody Screening for Transfusion Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Platelet Antibody Screening for Transfusion Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Platelet Antibody Screening for Transfusion Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Platelet Antibody Screening for Transfusion by Application
  1. 5.1 Platelet Antibody Screening for Transfusion Market by Application
  2. 5.1.1 HLA Antibodies
  3. 5.1.2 HPA Antibodies
  4. 5.2 Global Platelet Antibody Screening for Transfusion Market Size by Application
  5. 5.2.1 Global Platelet Antibody Screening for Transfusion Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Platelet Antibody Screening for Transfusion Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Platelet Antibody Screening for Transfusion Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Platelet Antibody Screening for Transfusion Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Platelet Antibody Screening for Transfusion Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Platelet Antibody Screening for Transfusion Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Platelet Antibody Screening for Transfusion Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Platelet Antibody Screening for Transfusion Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 apDia
  2. 6.1.1 apDia Company Information
  3. 6.1.2 apDia Business Overview
  4. 6.1.3 apDia Platelet Antibody Screening for Transfusion Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 apDia Platelet Antibody Screening for Transfusion Product Portfolio
  6. 6.1.5 apDia Recent Developments
  7. 6.2 Werfen
  8. 6.2.1 Werfen Company Information
  9. 6.2.2 Werfen Business Overview
  10. 6.2.3 Werfen Platelet Antibody Screening for Transfusion Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Werfen Platelet Antibody Screening for Transfusion Product Portfolio
  12. 6.2.5 Werfen Recent Developments
  13. 6.3 Aikang MedTech
  14. 6.3.1 Aikang MedTech Company Information
  15. 6.3.2 Aikang MedTech Business Overview
  16. 6.3.3 Aikang MedTech Platelet Antibody Screening for Transfusion Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aikang MedTech Platelet Antibody Screening for Transfusion Product Portfolio
  18. 6.3.5 Aikang MedTech Recent Developments
  19. 6.4 Tianjin Dexiang Biotech
  20. 6.4.1 Tianjin Dexiang Biotech Company Information
  21. 6.4.2 Tianjin Dexiang Biotech Business Overview
  22. 6.4.3 Tianjin Dexiang Biotech Platelet Antibody Screening for Transfusion Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tianjin Dexiang Biotech Platelet Antibody Screening for Transfusion Product Portfolio
  24. 6.4.5 Tianjin Dexiang Biotech Recent Developments
  25. 6.5 Shanghai Jianglai
  26. 6.5.1 Shanghai Jianglai Company Information
  27. 6.5.2 Shanghai Jianglai Business Overview
  28. 6.5.3 Shanghai Jianglai Platelet Antibody Screening for Transfusion Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Jianglai Platelet Antibody Screening for Transfusion Product Portfolio
  30. 6.5.5 Shanghai Jianglai Recent Developments
7 North America by Country
  1. 7.1 North America Platelet Antibody Screening for Transfusion Sales by Country
  2. 7.1.1 North America Platelet Antibody Screening for Transfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Platelet Antibody Screening for Transfusion Sales by Country (2021-2026)
  4. 7.1.3 North America Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032)
  5. 7.2 North America Platelet Antibody Screening for Transfusion Market Size by Country
  6. 7.2.1 North America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026)
  8. 7.2.3 North America Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Platelet Antibody Screening for Transfusion Sales by Country
  2. 8.1.1 Europe Platelet Antibody Screening for Transfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Platelet Antibody Screening for Transfusion Sales by Country (2021-2026)
  4. 8.1.3 Europe Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Platelet Antibody Screening for Transfusion Market Size by Country
  6. 8.2.1 Europe Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026)
  8. 8.2.3 Europe Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Country
  2. 9.1.1 Asia-Pacific Platelet Antibody Screening for Transfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Platelet Antibody Screening for Transfusion Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Platelet Antibody Screening for Transfusion Market Size by Country
  6. 9.2.1 Asia-Pacific Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Platelet Antibody Screening for Transfusion Sales by Country
  2. 10.1.1 South America Platelet Antibody Screening for Transfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Platelet Antibody Screening for Transfusion Sales by Country (2021-2026)
  4. 10.1.3 South America Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032)
  5. 10.2 South America Platelet Antibody Screening for Transfusion Market Size by Country
  6. 10.2.1 South America Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026)
  8. 10.2.3 South America Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Country
  2. 11.1.1 Middle East and Africa Platelet Antibody Screening for Transfusion Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Platelet Antibody Screening for Transfusion Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Platelet Antibody Screening for Transfusion Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Platelet Antibody Screening for Transfusion Market Size by Country
  6. 11.2.1 Middle East and Africa Platelet Antibody Screening for Transfusion Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Platelet Antibody Screening for Transfusion Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Platelet Antibody Screening for Transfusion Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Platelet Antibody Screening for Transfusion Value Chain Analysis
  2. 12.1.1 Platelet Antibody Screening for Transfusion Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Platelet Antibody Screening for Transfusion Production Mode & Process
  7. 12.2 Platelet Antibody Screening for Transfusion Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Platelet Antibody Screening for Transfusion Distributors
  10. 12.2.3 Platelet Antibody Screening for Transfusion Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst